# Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

> **NCT06597201** · PHASE4 · RECRUITING · sponsor: **Chengdu Qingshan Likang Pharmaceutical Co., Ltd** · enrollment: 400 (estimated)

## Conditions studied

- End Stage Renal Disease (ESRD)

## Interventions

- **DRUG:** amino acid (15) peritoneal dialysis solution
- **DRUG:** glucose peritoneal dialysis solution

## Key facts

- **NCT ID:** NCT06597201
- **Lead sponsor:** Chengdu Qingshan Likang Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-09
- **Primary completion:** 2025-06-29
- **Final completion:** 2025-06-29
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597201, "Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06597201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*